Jump to content
  • Sign Up
Scott Adams

Biolinerx Receives Notice Of Allowance For Us Patent Covering Novel ... - Marketwatch

Rate this topic

Recommended Posts

BioLineRx Receives Notice of Allowance for US Patent Covering Novel ...

MarketWatch

"We are very pleased to have received a Notice of Allowance from the USPTO for the BL-7010 patent," stated Dr. Kinneret Savitsky, Chief Executive Officer of BioLineRx. “BL-7010 for the treatment of celiac disease is one of our lead clinical programs ...

BioLineRx Ltd. (BLRX) Receives Notice of Allowance for BL-7010 Patent StreetInsider.com (subscription)

all 6 news articles »

View the full article

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


×
×
  • Create New...